leadxpro AG

Meeting Swiss innovation elite at Swiss Innovation Forum 2018

Swiss Innovation Forum (#SIF18) – Switzerland's biggest innovation fair – was held on Thursday, November 22, 2018, bringing together over a thousand...

More details

LEADXPRO SCIENTISTS CHART THE FUTURE OF STRUCTURE BASED DRUG DISCOVERY

In a series of scientific publications leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics. Medicines...

More details More details

New collaboration on a GPCR lead discovery project

Axxam SpA and leadXpro AG announce this week a collaboration for the discovery of novel small molecule lead compounds for a newly discovered GPCR involved...

More details More details

leadXpro about possibilities of new XFEL for applied research

Biotech startup leadXpro AG, at home at PARK INNOVAARE, applies serial crystallography among many other methods for structure-based drug design. It recently...

More details

Shaping the future of modern drug discovery

Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...

More details

Infrastructure and R&D solutions for biotech and pharmaceutical industries

The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...

More details

PARK INNOVAARE extends its lab space and acquires more office space on the PSI site

Already eight high-tech companies have joined PARK INNOVAARE, an innovation park located just a stone’s throw away from the Paul Scherrer Institute (PSI)....

More details

Unprecedented speed and success rate with delivering ligand-bound GPCR structures

Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...

More details

INNOVATION in PRACTICE 2017: achieving breakthrough innovation

No matter how important it is nowadays, innovation is unplannable. But it does not mean one cannot approach it in a structured manner. A series of workshops,...

More details

leadXpro “unlocks” new targets for structure-based drug discovery

One of the most promising groups of drug targets is that of integral membrane proteins. They are responsible for communicating signals from the outside...

More details
Subscribe to leadxpro AG